KR-39038（Cat No.:I043449）is an investigational small molecule compound being developed as a potential therapeutic for cancer. It works by inhibiting specific protein kinases involved in regulating critical cell signaling pathways that control tumor cell growth, survival, and metastasis. By targeting these kinases, KR-39038 aims to disrupt the tumor microenvironment and reduce cancer cell proliferation. The compound is being explored for its potential efficacy in various cancers, including those resistant to traditional therapies. Ongoing clinical trials are assessing its safety, pharmacokinetics, and potential to improve cancer treatment outcomes.